Vasta Platform Limited - Class A Ordinary Shares (VSTA)
4.9700
+0.0400 (0.81%)
NASDAQ · Last Trade: Nov 6th, 10:46 PM EST
Vasta Platform (VSTA) reported Q3 2025 revenue and earnings that missed analyst estimates, causing a negative market reaction despite some operational growth.
Via Chartmill · November 6, 2025
Via Benzinga · June 16, 2025
Via Benzinga · May 12, 2025

Vasta Platform just reported results for the first quarter of 2024.
Via InvestorPlace · May 9, 2024
Via Benzinga · April 8, 2025

What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Aug. 26-30, 2024.
Via Talk Markets · August 31, 2024

VSTA stock results show that Vasta Platform met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 7, 2024

US heat waves call for increased demand and prices for electricity and gas; 10 stocks to watch for benefits.
Via Benzinga · June 19, 2024

Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is expected to report quarterly earnings at $0.07 per share on revenue of $207.00 million.
Via Benzinga · March 20, 2024

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.
Via Benzinga · November 8, 2023

Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 124.2% to $0.1697 after falling 15% on Monday.
Via Benzinga · September 19, 2023

Via Benzinga · September 18, 2023

The most overbought stocks in the consumer discretionary sector presents an opportunity to go short on these overvalued companies.
Via Benzinga · September 15, 2023

Via Benzinga · August 31, 2023

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its first quarter.
Via Benzinga · May 11, 2023

Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter.
Via Benzinga · March 23, 2023
